ArticleFrontiers in oncology2021

Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature Review.

Vivek S Radhakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.